Nabuton Vp (Nabumetone)

Nabumetone, the active ingredient in Nabuton Vp, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis and other musculoskeletal conditions.

GNH USA supplies Nabuton Vp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable logistics across EU and global markets and timely delivery.

Nabumetone, an NSAID, reduces inflammation and pain in musculoskeletal disorders. - Osteoarthritis: alleviates joint pain and improves mobility. - Rheumatoid arthritis: decreases synovial inflammation and joint swelling. - Musculoskeletal pain: provides analgesic relief for acute or chronic soft‑tissue discomfort.

Nabumetone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: dyspepsia, abdominal pain or nausea. - Headache: mild to moderate intensity. - Dizziness: transient episodes of light‑headedness. - Rash: mild skin erythema or pruritus. - Edema: peripheral swelling, especially of the ankles. - Elevated liver enzymes: mild, asymptomatic increase.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding: potentially life‑threatening hemorrhage. - Hepatic injury: hepatitis or liver failure. - Renal impairment: acute kidney injury or reduced function. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: acute allergic reaction with airway compromise. - Cardiovascular events: myocardial infarction or stroke.

When prescribing nabumetone, clinicians should consider several safety precautions to minimize risk. - Assess gastrointestinal risk: evaluate history of ulcers or bleeding before use. - Monitor renal function: check serum creatinine and eGFR periodically. - Evaluate hepatic status: perform liver function tests at baseline and during therapy. - Use lowest effective dose: limit duration to the shortest period needed. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store at room temperature: keep in the original container, protect from moisture and heat.

Nabumetone can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Lithium: elevated lithium concentrations leading to toxicity.

Moderate Interactions (Monitor Closely): - Methotrexate: reduced clearance may increase toxicity. - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: enhanced risk of renal impairment and electrolyte imbalance.